Development of a method for the determination of vardenafil in human plasma by high performance liquid chromatography
Giuseppe Carlucci1, Paola Palumbo, Piera Iuliani
1Dipartimento di Scienze del Farmaco, Facoltà di Farmacia, Università degli Studi G. D'Annunzio, Chieti-Pescara, Chieti, Italy. g.carlucci@unich.it
Abstract:
A simple high-performance liquid chromatographic (HPLC) method with photometric detection is described for the determination of vardenafil hydrochloride, a phosphodiesterase V inhibitor, in human plasma. Chromatographic separation of the analyte and internal standard was achieved on an analytical 250 x 4.6 mm i.d. reversed-phase Kromasil KR 100 C(18) (5 microm particle size) column using a mobile phase of acetonitrile-potassium dihydrogen phosphate (30:70 v/v). The run time was less than 15 min. Column eluate was monitored at 230 nm. The linearity over the concentration range of 10-1500 ng/mL for vardenafil was obtained and the limit of quantification (LOQ) was 10 ng/mL. The method has been applied to analysis of the vardenafil concentrations for application in pharmacokinetic studies.
Related Concept Videos
High-Performance Liquid Chromatography: Types of Detectors
High-Performance Liquid Chromatography: Introduction
In HPLC, two phases play a critical role in the separation process:
High-Performance Liquid Chromatography: Instrumentation
High-Performance Liquid Chromatography: Elution Process
Chromatographic Methods: Classification
Chromatographic techniques are typically named by...

